findmyKOL

Andrew Kwa, MD

Basic profile

University of California Davis Medical Center

ORCIDNone on fileNPI
RegionSan Jose, CA · WestSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2012Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Andrew Kwa is a Cardiology physician affiliated with University of California Davis Medical Center. OpenAlex indexes 14 publications with 400 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
14publications

Distinct works indexed by OpenAlex.

400citations

Total citations across indexed works.

6h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
59companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2400 Samaritan Dr
Suite 200
San Jose, CA 951243910

Telephone

408-369-7500

Registry record last updated 27 Jun 2014.

View the NPPES registry record

Industry payments

59 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    84.8%
    Beta blocker20.4%
    Metoprolol Succinate64%Metoprolol Tartrate13%Carvedilol8%Atenolol7%Nebivolol Hcl4%Sotalol3%Sotalol Af1%
    Part D<11 patients
    Statin14%
    Atorvastatin Calcium59%Rosuvastatin Calcium33%Simvastatin4%Pravastatin Sodium3%Livalo2%
    Part D<11 patients

    + 18 more classes in this area

  • Blood & clotting

    13.4%
    Factor Xa inhibitor10.9%
    Eliquis84%Xarelto16%
    Part D157 patients
    P2Y12 inhibitor2.1%
    Clopidogrel67%Brilinta33%
    Part D35 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    1.9%
    SGLT2 inhibitor0.8%
    Farxiga100%
    Part D21 patients
    Potassium supplement0.8%
    Potassium Chloride100%
    Part D16 patients

    + 1 more class in this area

Where care is delivered (Part B)13.7% facility · 86.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

8 more publications behind the reveal.Reveal →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”